CRISPR Therapeutics
CRSP
#3489
Rank
โ‚ฌ2.55 B
Marketcap
29,78ย โ‚ฌ
Share price
-0.03%
Change (1 day)
-50.39%
Change (1 year)

CRISPR Therapeutics (CRSP) Fails to deliver data

Key failure to deliver metrics for CRISPR Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for CRISPR Therapeutics (CRSP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for CRISPR Therapeutics (CRSP) - since 2016

Volume in USD (price x number of shares), data since 2016

CRISPR Therapeutics (CRSP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025โ‚ฌ30.52 M-80.67%
2024โ‚ฌ0.15 B6.44%
2023โ‚ฌ0.14 B1.4%
2022โ‚ฌ0.14 B8.89%
2021โ‚ฌ0.13 B22.76%
2020โ‚ฌ0.10 B-2.51%
2019โ‚ฌ0.11 B59.97%
2018โ‚ฌ70.19 M265.26%
2017โ‚ฌ19.21 M319.28%
2016โ‚ฌ4.58 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ4.65 Mโ‚ฌ8.47 M๐Ÿ‡บ๐Ÿ‡ธ USA